Could a spinal cord device ease stubborn leg pain in diabetes and PAD?

NCT ID NCT06480786

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether high-frequency spinal cord stimulation can reduce leg pain and improve quality of life in people with both peripheral arterial disease (PAD) and painful diabetic neuropathy. Fifteen adults who already have a spinal cord stimulator implanted will receive two weeks of active stimulation and two weeks of sham (inactive) stimulation in random order. Researchers will measure pain, blood flow, skin oxygen levels, and quality of life to see if the device helps beyond a placebo effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

spinal cord stimulation (device)

What this could lead to

If it works, this could point toward a new way to manage chronic leg pain in people with both PAD and diabetic neuropathy, improving quality of life.

What could go wrong

This is a very small, early proof-of-concept trial with only 15 participants. The sham control may not fully blind participants, and results may not apply to everyone with these conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome diabetic neuropathy peripheral arterial disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Nebraska Medical Center

    RECRUITING

    Omaha, Nebraska, 68198, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••